Members Only Content

Subscribe to get full access

Free Preview

For the very first time, 7investing is revealing one of our previous recommendation reports! Dicerna Pharmaceuticals was recently acquired by Novo Nordisk in a $3.3 billion deal. We're taking this opportunity to showcase some of our previous research of what we liked about the pre-commercial drug developer using RNAi to control gene expression.

DNA Strand model standing on a floor rug

related news & insights

  • 7investing logo next to the Upstart logo.
    June 12, 2025||0 min||||

    Upstart Deep Dive: June 2025

    Upstart Recommendation Report Upstart Presentation Slides

  • May 30, 2025||0.8 min||||

    7investing Exclusive: A Deep Dive Into Lemonade

    Lemonade (NYSE: LMND) is a new player who's really adding zest to the insurance industry. Its AI-powered underwriting enables it to [...]

  • May 16, 2025||46.1 min||||

    What’s Next for Digital Advertising? 7investing Interviews PubMatic CEO Rajeev Goel

    PubMatic just reported first quarter 2025 results. Aside from the headwinds of a DSP partner changing its bidding process, the [...]